We are a research and development company operating in both the biotech and agtech sectors, with an intellectual property portfolio comprised of proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques and patented or patent-pending inventions for applications in human and animal health. We believe that our proprietary a…
$4.40
$0.20 (-4.35%)
Price from 6 days ago
The business is unprofitable at the operating level (-8498.85% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 468.6% YoY with margins expanding 17768.8pp.
ROIC dropped from -1278.70% to -6095.65%, capital efficiency is deteriorating. Negative free cash flow of -$4M. The business is consuming cash, not generating it.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$209K
▲ +468.6% YoY
Net Income (TTM)
-$8M
▼ -72.1% YoY
Op. Margin
-4045.65%
▲ +17768.8pp YoY
ROIC
-1540.30%
▼ -4816.9pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$3M
▲ +25.6% YoY
Op. Cash Flow (TTM)
-$3M
▲ +25.6% YoY
Net Debt
$368K
Cash & Equiv.
$57K
Continue Research